About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Breast Cancer Researchers Urged to Consider Subjects' Ethnicity

by VR Sreeraman on July 20, 2008 at 12:39 PM
 Breast Cancer Researchers Urged to Consider Subjects' Ethnicity

Experts at Imperial College London have urged breast cancer researchers to investigate how a person's ethnicity influences their response to treatment and its outcome.

In a piece of comment published in the peer-reviewed medical journal The Lancet, they write that there is evidence that particular medications may benefit people from one ethnic group more than others because of differences in their genetic makeup.

Advertisement

The experts highlight the fact that most key trials looking at treatments for breast cancer have been carried out in predominantly white populations in Europe, North America and Australasia.

They argue that other populations may not respond to a medicine in the same way as the white populations in such trials.

They believe that participants' ethnicity should be recorded during clinical trials, and analyses should be carried out to see where there are any differences in how patients from particular ethnic groups respond to a particular therapy.
Advertisement

The researchers even refer to recent studies that showed that people with a particular genotype responded better than others to a drug called trasztuzumab, which is commonly used to treat people with breast cancer that is HER-2 positive.

"Everyone responds differently to treatment and it's often very difficult to predict how well someone will respond to a particular drug. However, evidence is now emerging that shows how your genes might influence whether or not a particular treatment can help you," said Dr. Carlo Palmieri, from the Division of Surgery, Oncology, Reproductive Biology and Anaesthetics at Imperial College London and one of the authors of the piece.

"There are small genetic differences between people from different ethnic backgrounds and it is really important that we find out whether these genetic differences mean that certain drugs perform well in people from certain ethnic groups but not in others. It's only by doing this that we can make sure each individual receives the best possible care," added Dr. Palmieri.

Source: ANI
SRM
Font : A-A+

Advertisement

Advertisement
Advertisement

Recommended Readings

Latest Cancer News

Personalized Vaccine and T Cell Therapy for Ovarian Cancer Patients
The combination of the personalized cancer vaccine with ACT led to ovarian cancer control in few patients within a span of three months, stated study results.
Kinase-Targeted Therapy Revolutionizes Colorectal Cancer Care
Uncovering key kinases in tumor growth and invasion is crucial for improving targeted therapies in advanced-stage colorectal cancer.
Novel Photo-Oxidation Therapy Holds Promise for Anticancer Treatment
The study findings validate metal-enhanced photo-oxidation for future metal-based anticancer drugs.
Mutations in 11 Genes Linked to Aggressive Prostate Cancer
Mutations in 11 genes are linked to aggressive forms of prostate cancer, which may present novel therapeutic and therapy options.
Link Between Poor Oral Health and Head & Neck Cancer Survival Uncovered
Improved oral health, as indicated by the count of natural teeth and dental appointments preceding the diagnosis, correlated with enhanced head and neck cancer survival rates.
View All
This site uses cookies to deliver our services.By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use  Ok, Got it. Close
MediBotMediBot
Greetings! How can I assist you?MediBot
×

Breast Cancer Researchers Urged to Consider Subjects' Ethnicity Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests